Valens Company, Inc.
DelistedCIK 1859902fmd_0ZHN0SH39GFQC0YYHFWVQKHKR2Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Dec 01, 2019 to Nov 30, 2021, 2 periods
| Line item | FY2020 | FY2021 |
|---|---|---|
| Total revenues | 84 | 78 |
| Cost of revenue | 58 | 61 |
| Gross profit | 26 | 17 |
| Selling, general and administrative | 26 | 54 |
| Operating income | (21) | (55) |
| Income before taxes | (23) | (55) |
| Income tax expense | (2) | (6) |
| Net income from continuing operations | (21) | (49) |
| Net income | (21) | (49) |